Scientific article
OA Policy
English

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis

Published inArthritis Research and Therapy, vol. 19, no. 1, 164
Publication date2017
Abstract

Few studies have investigated the impact of obesity on the response to tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA). The aim of our study was to investigate the impact of different body mass index (BMI) categories on TNFi response in a large cohort of patients with axSpA.

Keywords
  • Adult
  • Anti-Inflammatory Agents/therapeutic use
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Obesity/complications
  • Spondylarthritis/drug therapy
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha/antagonists & inhibitors
Citation (ISO format)
MICHEROLI, Raphael et al. Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. In: Arthritis Research and Therapy, 2017, vol. 19, n° 1, p. 164. doi: 10.1186/s13075-017-1372-3
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Journal ISSN1478-6354
410views
168downloads

Technical informations

Creation04/09/2018 10:07:00
First validation04/09/2018 10:07:00
Update time03/02/2025 12:57:55
Status update03/02/2025 12:57:55
Last indexation03/02/2025 13:02:23
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack